NeuN+ CC3+ double-positive neurons were extremely scarce and no differences were found between MS and controls (0.08 ± 0.04% of NeuN+ cells in MS and 0.18 ± 0.14% in controls) (suppl. This evidence concerns the gene RBFOX3 and myeloid sarcoma.